Jill Bargonetti Selected Research

mitosene

7/2010

DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jill Bargonetti Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 10/2002
18	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2008
4	Triple Negative Breast Neoplasms 06/2021 - 11/2012
2	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2014
2	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2023
2	Carcinogenesis 03/2012 - 01/2012
1	Inflammation (Inflammations) 01/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2015
1	Disease Progression 12/2012
1	Fanconi Anemia (Fanconi's Anemia) 12/2008
1	Necrosis 06/2007

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2012
9	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2008
6	ChromatinIBA 01/2024 - 01/2015
6	Protein Isoforms (Isoforms)IBA 12/2022 - 01/2008
5	Estrogens (Estrogen)FDA Link 01/2019 - 01/2008
5	Estrogen ReceptorsIBA 01/2019 - 01/2011
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 01/2020
3	Alkylating AgentsIBA 01/2024 - 06/2007
3	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 10/2022
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2024 - 12/2015
3	talazoparibIBA 01/2024 - 10/2022
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
2	Peptides (Polypeptides)IBA 01/2024 - 01/2021
2	Drug CombinationsIBA 01/2024 - 06/2023
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2022 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 08/2019 - 04/2006
2	ProteomeIBA 03/2015 - 03/2012
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2015 - 12/2008
2	Proto-Oncogene Proteins c-mdm2IBA 01/2014 - 03/2012
1	IsotopesIBA 01/2024
1	Mutant Proteins (Protein, Mutant)IBA 01/2024
1	Neutralizing AntibodiesIBA 01/2024
1	CytokinesIBA 01/2024
1	olaparibIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2020
1	AntibodiesIBA 02/2019
1	Monoclonal AntibodiesIBA 02/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	Gemcitabine FDA Link 11/2012
1	Etoposide (VP 16)FDA LinkGeneric 11/2012
1	RNA (Ribonucleic Acid)IBA 03/2012
1	NucleotidesIBA 03/2012
1	Messenger RNA (mRNA)IBA 03/2012
1	Mevalonic Acid (Mevalonate)IBA 01/2012
1	SterolsIBA 01/2012
1	Estrogen Receptor alphaIBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011
1	mitoseneIBA 07/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2008
1	NucleosidesIBA 12/2008
1	DeoxyguanosineIBA 12/2008
1	nutlin 3IBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 04/2006
1	Tumor Suppressor Protein p53IBA 07/2005
1	Phorbol EstersIBA 03/2004
1	Protein Kinase CIBA 03/2004
1	2,7-diaminomitoseneIBA 10/2002
1	DNA AdductsIBA 10/2002

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2011
2	Drug Therapy (Chemotherapy) 10/2015 - 11/2012
1	Ligation 01/2024
1	Cardiopulmonary Resuscitation (CPR) 01/2024
1	Precision Medicine 01/2021